Skip to content

Outcome After Radial Pressure Wave Therapy in Plantar Fasciitis.

CompletedNCT06813105
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The goal of this observational study is to explore potential associations between baseline patient characteristics (such as age, body mass index, and baseline pain intensity) and clinical outcomes in patients with plantar fasciitis undergoing radial pressure wave therapy (RPWT). The study includes male and female adults aged 18 to 60 years.

Study details

Official title
Exploratory Analysis of Pain and Function Improvement After Radial Pressure Wave Therapy in Plantar Fasciitis.
Conditions
  • Fasciitis, Plantar
  • Fasciitis, Plantar, Chronic
Sponsor
Hospital Civil de Guadalajara
Collaborators
University of Guadalajara
Start date
2024-11-19
Primary completion
2024-12-26
Sex
All
Age range
from 18 Years to 60 Years
Results posted
No results posted in this snapshot
Countries
Mexico
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosis of plantar fasciitis confirmed by clinical evaluation. * Age 18 to 60 years. * Symptoms persisting for at least three months before treatment. * Completed three RPWT sessions using a standardized protocol (2000 impulses per session, 10 Hz, and 3.5 bar). * Availability of complete medical records, including three-month follow-up data. Exclusion Criteria: * History of foot surgery or corticosteroid injection in the affected limb within the past six months. * Pregnancy at the time of treatment. * Presence of concurrent musculoskeletal conditions (e.g., fractures, active infections, sprains) in the affected limb. * Diagnosis of systemic conditions (e.g., cancer, osteoporosis, autoimmune diseases). * Incomplete medical records or failure to complete RPWT sessions and follow-up visits.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06813105